Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis

• Published in: Healthcare (Basel) Vol. 12; no. 15; p. 1487
• Main Authors: Davey, Pinakin Gunvant, Farid, Marjan, Karpecki, Paul, Gaddie, Ian Benjamin, Chan, Arthur, Mun, James, Neervannan, Sesha, Yeu, Elizabeth
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.08.2024
• Subjects: blepharitis; Clinical trials; Demodex; dry eye; Erythema; Eye diseases; Eyelids; FDA approval; Health aspects; Inflammation; lotilaner; Mites; Pharmacists; United States; United States > US; Mexico

Demodex blepharitis, a chronic lid margin disease, is caused by an infestation of Demodex mites, the most common ectoparasites in human skin and eyelids. Lotilaner ophthalmic solution, 0.25% (Xdemvy, Tarsus Pharmaceuticals), is the first therapy approved to treat Demodex blepharitis. This narrative...